NasdaqCM - Nasdaq Real Time Price USD

Pluri Inc. (PLUR)

4.8732
-0.0768
(-1.55%)
At close: 4:00:00 PM EDT
5.0000
+0.13
+(2.60%)
After hours: 5:23:04 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
1,034
326
287
234
0
Cost of Revenue
495
4
9
0
0
Gross Profit
539
322
278
234
0
Operating Expense
22,128
22,480
27,524
41,827
50,623
Operating Income
-21,589
-22,158
-27,246
-41,593
-50,623
Net Non Operating Interest Income Expense
281
540
225
-331
391
Other Income Expense
-35
274
-1,866
550
367
Pretax Income
-21,343
-21,344
-28,887
-41,374
-49,865
Net Income Common Stockholders
-20,714
-20,888
-28,321
-41,242
-49,865
Diluted NI Available to Com Stockholders
-20,714
-20,888
-28,321
-41,242
-49,865
Basic EPS
-3.63
-3.99
-6.24
-10.24
-14.16
Diluted EPS
-3.63
-3.99
-6.24
-10.24
-14.16
Basic Average Shares
5,738.2000
5,240.2490
4,581.5030
4,024.0090
3,514.2040
Diluted Average Shares
5,738.2000
5,240.2490
4,581.5030
4,024.0090
3,514.2040
Total Operating Income as Reported
-21,589
-22,158
-27,246
-41,593
-50,623
Total Expenses
22,623
22,484
27,533
41,827
50,623
Net Income from Continuing & Discontinued Operation
-20,714
-20,888
-28,321
-41,242
-49,865
Normalized Income
-20,679
-21,162
-26,455
-41,792
-50,232
Interest Income
1,047
1,314
1,084
581
492
Interest Expense
858
866
843
887
78
Net Interest Income
281
540
225
-331
391
EBIT
-20,485
-20,478
-28,044
-40,487
-49,787
EBITDA
-20,219
-20,225
-27,682
-39,434
-48,417
Reconciled Cost of Revenue
495
4
9
0
0
Reconciled Depreciation
266
253
362
1,053
1,370
Net Income from Continuing Operation Net Minority Interest
-20,714
-20,888
-28,321
-41,242
-49,865
Total Unusual Items Excluding Goodwill
-35
274
-1,866
550
367
Total Unusual Items
-35
274
-1,866
550
367
Normalized EBITDA
-20,184
-20,499
-25,816
-39,984
-48,784
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
6/30/2021 - 6/30/2003

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CANF Can-Fite BioPharma Ltd.
1.0550
+0.96%
 
PPBT Purple Biotech Ltd
2.4100
+3.43%
 
EVGN Evogene Ltd.
1.2700
-7.97%
 
DSGN Design Therapeutics, Inc.
3.6700
+3.97%
 
BLRX BioLineRx Ltd.
3.6400
+13.40%
 
XTLB XTL Biopharmaceuticals Ltd.
1.1000
0.00%
 
ORMP Oramed Pharmaceuticals Inc.
2.1500
+0.47%
 
NRSN NeuroSense Therapeutics Ltd.
1.6300
+18.12%
 
DTIL Precision BioSciences, Inc.
4.8800
+4.05%
 
PLX Protalix BioTherapeutics, Inc.
1.7200
+2.38%